Appears to enhance weightloss and glucose effects when combined with GLP1, based on dualagonist data (such as tirzepatide). Glucagon receptor activation Increases energy expenditure and promotes fat oxidation when balanced properly with GLP1 and GIP. May help reduce liver fat and visceral (deep abdominal) fat, which are strongly linked to cardiometabolic risk. By combining these three pathways, retatrutide aims to reduce appetite, improve metabolic control, and increase calorie burning more strongly than current single or dualagonist drugs
When used strategically alongside therapies like TRT or peptide-based hormone optimization, it helps patients address multiple aspects of sexual and hormonal health in a holistic way
Read more at LearnSkin to help understand food triggers leading to clearer skin
Sleep loss and lower sleep duration may be associated with lower morning, afternoon and 24-h testosterone levels
From there, the remote care company seeks to support patients in their clinical journeys using digital tools, like patient messaging and prompted, automated check-ins
